|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes. a review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: analysis of the returned device identified overweight, deformation, crease fold.Cloudy and voids in the gel observed after autoclave cycle.After weighting the device, it is observed that it is overweight, however, a review of the weight reports generated during the manufacturing process is performed and all units were within specification.Therefore, the overweight observed during the additional analysis is not considered a workmanship (see the weight report attached).Based on the device analysis the final assessment is: no issues found related with the manufacturing process.The event of pain is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: pain.
|